Nasal immune adjuvant protects mice against respiratory viruses for months
The COVID-19 pandemic showed the challenges of protecting populations when a new respiratory virus emerges.
Read original article on The Medical News →Related news
-
Global cardiac rehabilitation access stagnates despite rising cardiovascular disease
-
Tiny archaeon offers new clues to the minimum genetic requirements for life
-
Improving the steps toward better, cost-effective PTSD treatment
-
Molecular regulator CA8 may offer new therapeutic target for type 2 diabetes
-
Global survey finds gaps in pediatric cardiac troponin testing
-
New project aims to predict early protein dysfunction in neurodegenerative diseases
-
Long-term cannabis use may disrupt sleep without noticeable symptoms
-
'Medicare for All' is back: Now comes the hard part